Evaluation of the Short Parkinson's Evaluation Scale: A new friendly scale for the evaluation of Parkinson's disease in clinical drug trials

Clinical Neuropharmacology

Volumn 20, Issue 4, 1997, Pages 322-337

  Rabey, Jose Martin ^a,h   Bass, Horst ^b   Bonuccelli, Ubaldo ^c   Brooks, David ^d   Klotz, Peter ^e   Korczyn, Amos D ^a   Kraus, Peter ^e   Martinez Martin, Pablo ^f   Morrish, Paul ^d   Van Sauten, Wanda ^g   Van Hilten, Bob ^g  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL OF PISA   (Italy)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

^e ST JOSEF HOSPITAL   (Germany)

^f HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Parkinson's disease; Rating scales; Short Parkinson's Evaluation Scale; Unified Parkinson's Disease Rating Scale

Indexed keywords

ADULT; AGED; ARTICLE; BODY POSTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EATING; FEEDING; FEMALE; GAIT; HUMAN; HYGIENE; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; RELIABILITY; SELF CARE; SPEECH; TASK PERFORMANCE; TREMOR; WRITING;

EID: 0030742086     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199708000-00004     Document Type: Article

References (22)

1. Lang AE. Clinical rating scales and videotape analysis. In: Koller WC, Paulson G, eds. Therapy of Parkinson's disease. 2nd ed. New York: Marcel Dekker, 1995:21-46.
2. Martinez-Martin P. Ratine scales in Parkinson's disease. In: Jankovic J, Tolosa E, eds. Parkinson's disease and movement disorders. 2nd ed. Baltimore: Williams and Wilkins, 1993:281-92.
3. Fahn S, Elton RL, and members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In- Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent developments in Parkinson's disease; vol 2. Florham Park, NJ: Macmillan Health Care Information, 1987:153-64.
4. Parkinson's Study Group. Effect of deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 1989;321:1364-71.
5. Goetz CG, Olanow CW, Koller, et al. Adrenal medullary transplants to the striatum of patients with advanced Parkinson's disease: multicenter study. N Engl J Med 1989;320:337-41.
6. Richards M, Marder K, Cote L, Mayeaux R. Interrater reliability of the Unified Parkinson's Disease Rating Scale. Mov Disord 1994;9:89-91.
7. Martinez-Martin P, Gil-Nagel A, Morlan Garcia L, Balshero Gomez J, Martinez-Sarries J, Bermejo F, and the Cooperative Multicentric Group. Unified Parkinson's Disease Rating Scale: characteristics and structure. Mov Disord 1994;9:76-88.
8. Van Hilten JJ, van der Zwan AD, Zwinferman AH, Roos RAC. Rating impairment and disability in Parkinson's disease: evaluation of the Unified Parkinson's Disease Rating Scale. Mov Disord 1994;9:84-8.
9. Siegel S, Castellan NJ. Non-parametric statistics for the behavioural sciences. New York: McGraw-Hill, 1988.
10. Marsden DS, Parkes JD. On and off variability and response swings in Parkinson's disease. In: Rose FC, Capildeo R, eds. Research progress in Parkinson's disease. Kent, UK: Pitman Medical, 1981:265-73.
11. De Mari M, Margarie L, Lamberti P, Iliceto G, Ferrari E. Changes in the amplitude of the N30 frontal component of SPES during apomorphine test in parkinsonian patients. J Neurol Transm 1995;45:171-6.
12. Rabey JM, Streifler M, Treves T, Korczyn AD. A long-term comparative study of lisuride and levodopa in Parkinson's disease. In: Calno DB, Comi G, Crippa D, Horowski R, eds. Parkinsonism and aging. New York: Raven, 1989:261-7.
13. 2 agonist in the treatment of Parkinson's disease. Clin Neuropharmacol 1994:286-93.
14. Henderson L, Kennard C, Crawford TJ, et al. Scales for rating motor impairment in Parkinson's disease: studies of reliability and convergent validity. J Neurol Neurosurg Psychiatry 1991;54:18-24.
15. Goetz GG, Stabins GT, Chmura TA, Fahn S, Klawans HL, Marsden CD. Teaching tape for the motor section of the Unified Parkinson's Disease Rating Scale. Mov Disord 1995;3:263-6.
16. Marsden CD, Schachter M. Assessments of extrapyramidal disorders. Br J Clin Pharmacol 1981;11:129-51.
17. Rabey JM, Korczyn AD. The Hoehn and Yahr Rating Scale for Parkinson's disease. In: Przuntek H, Kraus PH, Korcyn AD, eds. Instrumental methods and scoring in diagnosis, and quantifications of extrapyramidal disorders. Berlin: Springer-Verlag, 1995:10-5.
18. Lieberman A, Dziatolowski M. Gopinathan G, Kupersmith M, Neophytides A, Korein J. Evaluation of Parkinson's disease. In: Goldstein M, Calne DB, Liebeman A, Thormer MD, eds. Ergot compounds and brain function: neuroendocrine and ineuropsychiatric aspects. New York: Raven, 1980:277-86.
19. Montgomory GK, Reynolds NC, Warren RM. Qualitative assessment of Parkinson's disease; a study of reliability and data reduction with an abbreviated Columbia scale. Clin Neuropharmacol 1985;8:83-92.
20. Reynolds NC, Montgomery GK. Factor analysis of Parkinson's impairment: an evaluation of the final common pathway. Arch Neurol 1987;33:1013-6.
21. Baas H, Stecker K, Fischer PA. Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease. J Neurol Transm (PD sect) 1993;5:45-61.
22. Zetusky WJ, Jankovic J. Pirozzolo FJ. The heterogeneity of Parkinson's disease: clinical and prognostic implications. Neurology 1985;35:522-6.